Flush-Free Niacin 500 mg

Flush-Free Niacin 500 mg

Protocol For Life Balance4.7 (68 ratings)
Format:Capsule Quantity: 90 Capsule(s) · 90 servings
Goals
$25.00 $0.27 per serving

About this product

The product is aimed at people who want substantial niacin without the classic flush. Inositol supports that positioning, but the ingredient lines do not specify whether the niacin is bound as inositol hexanicotinate.

A large amount may cover vitamin B3 needs many times over. Without a precise form, the likely effects on skin, lipids, and tolerance remain uncertain.

The formula may be reasonable for a user who values comfort and can verify the current label. It is not a dependable substitute for clearly labeled nicotinic acid in a cardiovascular plan.

Who is it for
  • Adults seeking a lower-flush niacin capsule
  • Users willing to verify form details
  • People focused on general vitamin B3 intake
Best for
  • Tolerance-focused niacin use
  • Vitamin B3 plus inositol
  • Capsule-based routines

Pros

  • Large vitamin B3 amount
  • Includes inositol
  • Designed to reduce flushing

Cons

  • Bound niacin form is not named
  • Higher serving cost than basic niacin
  • Heart-specific effects remain uncertain

Warnings

  • Do not assume the product has nicotinic acid's lipid effects merely because the dose is large.
  • High-dose vitamin B3 may still cause nausea or affect liver markers during prolonged use.
  • Verify the exact form before combining it with another niacin supplement.

Product analysis

70 out of 100
A high-dose, lower-flush niacin option whose exact form is not clearly established. Better disclosure would improve confidence in both tolerance and goal fit.

AI assessment of the formula, label and price. How scoring works

Nutrient quality72

Flush-free positioning suggests an inositol-bound form, but the exact compound is not identified. The stated niacin amount is substantial for a no-flush formula.

.
Ingredient transparency71

The core amount is shown, but parts of the active labeling remain ambiguous. The supplied data does not include a complete inactive ingredient list.

.
Customer satisfaction62

The aggregate satisfaction measure is strong, but the small evidence base limits confidence. Missing feedback themes leave recurring complaints and purpose fit uncertain.

.
Value for money72

The price is only partly justified by the formula quality and dose. Each serving provides only moderate cost efficiency.

.
Format
Capsule
Container
90 Capsule(s)
Per serving
$0.27
Customer rating
4.7 · 68 ratings
Report analysis

Goals

Heart Health
Impact
Moderate effect
B+ Ingredient FitF PathwaysC EvidenceA+ Formulation Logic
Study evidence
Niacin Supportive 105 studies

Ingredients

IngredientAmount per servingScore
Niacin (Vitamin B3)
500 mg 65
Inositol
135 mg
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
Niacin (Vitamin B3) · 500 mg OverallScore65
C- Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyC Value
This capsule identifies Inositol Hexanicotinate and clearly lists 500 mg of niacin. It also carries a Flush-Free label, which makes the form easier to identify, though the source-compound amount isn't reconciled with the nutrient amount. Its serving cost is moderate.
How this ingredient is rated

Active Ingredient Quality & Bioavailability57

The product names Inositol Hexanicotinate, but no specific niacin-related goal or additional source verification is stated.
Niacin Form & Goal Alignment
The form is identified, but no specific niacin-related goal is listed.
Precursor Source Quality
It identifies IHN, but no additional source verification is stated.

Dose, Safety & Label Transparency75

The label identifies the form and nutrient amount, while keeping the source-compound amount distinct.
Clarity of Chemical Form
It explicitly identifies Inositol Hexanicotinate.
Form-Specific Dosage Efficacy
The niacin amount is 500 mg; its relation to the IHN compound mass isn't given.
Flush Risk & Safety Labeling
It explicitly labels the product as Flush-Free.

Value60

The serving cost sits in a moderate range for this form.
Price Per Effective Serving
Cost per serving is moderate for IHN.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
    Duggal JK; Singh M; Attri N; Singh PP; Ahmed N; Pahwa S; Molnar J; Singh S; Khosla S; Arora R · Journal of cardiovascular pharmacology and therapeutics · 2010
    Meta-analysis5,137 participants7 studies pooledHeart Health forNiacin
  2. Role of Niacin in Current Clinical Practice: A Systematic Review.
    Garg A; Sharma A; Krishnamoorthy P; Garg J; Virmani D; Sharma T; Stefanini G; Kostis JB; Mukherjee D; Sikorskaya E · The American journal of medicine · 2017
    Meta-analysis35,206 participants13 studies pooledHeart Health forNiacin
  3. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
    Guyton JR; Slee AE; Anderson T; Fleg JL; Goldberg RB; Kashyap ML; Marcovina SM; Nash SD; O'Brien KD; Weintraub WS; Xu P; Zhao XQ; Boden WE · Journal of the American College of Cardiology · 2013
    Randomized trial3,414 participantsHeart Health Cardiovascular Support forNiacin
  4. Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis.
    D'Andrea E; Hey SP; Ramirez CL; Kesselheim AS · JAMA network open · 2020
    Meta-analysis35,760 participants17 studies pooledHeart Health forNiacin
  5. Exploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review.
    Shoukfeh R; Tisack AM; Lim HW; Mohammad TF · Journal of drugs in dermatology : JDD · 2025
    Narrative reviewHeart Health forNiacin
  6. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
    Villines TC; Stanek EJ; Devine PJ; Turco M; Miller M; Weissman NJ; Griffen L; Taylor AJ · Journal of the American College of Cardiology · 2010
    Randomized trial315 participantsHeart Health forNiacin
  7. Niacinamide: A B vitamin that improves aging facial skin appearance.
    Bissett DL; Oblong JE; Berge CA · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2005
    Randomized trial50 participantsSkin Health forNiacin
  8. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
    Hakozaki T; Minwalla L; Zhuang J; Chhoa M; Matsubara A; Miyamoto K; Greatens A; Hillebrand GG; Bissett DL; Boissy RE · The British journal of dermatology · 2002
    Randomized trial138 participantsSkin Health forNiacin
  9. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.
    Mainville L; Smilga AS; Fortin PR · Journal of cutaneous medicine and surgery · 2022
    Meta-analysis3,039 participants29 studies pooledSkin Health forNiacin
  10. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL · The New England journal of medicine · 2023
    Randomized trial158 participantsSkin Health forNiacin
  11. Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide.
    Kawada A; Konishi N; Oiso N; Kawara S; Date A · The Journal of dermatology · 2008
    Randomized trial30 participantsSkin Health forNiacin
  12. A Foodborne Outbreak Traced to Niacin Overenrichment.
    Hudson PJ; Vogt RL · Journal of food protection · 2023
    Case-control study21 participantsSkin Health forNiacin
  13. Nicotinamide for Skin Cancer Chemoprevention.
    Breglio KF; Knox KM; Hwang J; Weiss R; Maas K; Zhang S; Yao L; Madden C; Xu Y; Hartman RI; Wheless L · JAMA dermatology · 2025
    Cohort study33,822 participantsSkin Health forNiacin
  14. Chemoprevention of keratinocyte carcinomas and actinic keratoses in adults who were immunocompetent: a systematic review.
    Susanto A; Morgan E; Lindsay D; Collins LG · Clinical and experimental dermatology · 2026
    Systematic review7,355 participants11 studies pooledSkin Health forNiacin
  15. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
    Lavigne PM; Karas RH · Journal of the American College of Cardiology · 2013
    Meta-analysis9,959 participants11 studies pooledCardiovascular Support forNiacin
  16. Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
    Saboori S; Yousefi Rad E; Tammam J; Thondre PS; Coe S · The British journal of nutrition · 2024
    Meta-analysis12 studies pooledCardiovascular Support forNiacin
  17. Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy.
    Philpott AC; Hubacek J; Sun YC; Hillard D; Anderson TJ · Atherosclerosis · 2013
    Randomized trial66 participantsCardiovascular Support forNiacin
  18. Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar.
    Jenkins DJA; Spence JD; Giovannucci EL; Kim YI; Josse RG; Vieth R; Sahye-Pudaruth S; Paquette M; Patel D; Blanco Mejia S; Viguiliouk E; Nishi SK; Kavanagh M; Tsirakis T; Kendall CWC; Pichika SC; Sievenpiper JL · Journal of the American College of Cardiology · 2021
    Meta-analysisCardiovascular Support forNiacin
  19. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.
    Elam MB; Hunninghake DB; Davis KB; Garg R; Johnson C; Egan D; Kostis JB; Sheps DS; Brinton EA · JAMA · 2000
    Randomized trial468 participantsCardiovascular Support forNiacin
  20. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
    Superko HR; McGovern ME; Raul E; Garrett B · The American journal of cardiology · 2004
    Randomized trial180 participantsHeart Health forNiacin
  21. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Thoenes M; Oguchi A; Nagamia S; Vaccari CS; Hammoud R; Umpierrez GE; Khan BV · International journal of clinical practice · 2008
    Randomized trial50 participantsHeart Health forNiacin
  22. Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A · Vascular medicine (London, England) · 2014
    Meta-analysis441 participants7 studies pooledHeart Health forNiacin